Latest Racing News

Chilwa Minerals has confirmed a significant carbonatite mineral system hosting critical rare earth elements at its Lake Chilwa project, with ongoing diamond drilling underway at the Mposa anomaly.

Arcadia Minerals is gearing up for a significant drilling campaign at its Karibib Copper Gold Project while navigating a competitive funding process for the Swanson Tantalum Mine. Strategic partnerships remain central to the company’s growth plans amid cautious lithium market conditions.

FBR Limited wraps up its US Demonstration Program, secures $6.3 million in capital, and appoints Mark Pivac as CEO amid a 70% cost reduction drive. Strategic collaborations with Samsung Heavy Industries and Liebherr signal broader automation ambitions.

Power Minerals Limited has taken a significant step in expanding its South American critical minerals portfolio by signing a binding option to acquire the high-grade Santa Anna Niobium Project in Brazil, supported by a strategic US$300,000 investment and a $1.3 million placement to fund exploration.

Axel REE Limited advances its flagship Caladão REE-Gallium Project with significant high-grade intercepts and begins a maiden Mineral Resource Estimate, backed by $9.6 million in cash and strategic government partnerships.

Petratherm Limited has confirmed a significant titanium-rich heavy mineral sands discovery at its Muckanippie Project, with drilling extending mineralisation over 15 square kilometres and a recent $8.1 million placement to accelerate development.

Kuniko Limited has streamlined its Norwegian battery metals portfolio, pursued non-dilutive green funding, and forged AI satellite data partnerships, setting the stage for growth in Europe’s critical minerals sector.

Delorean Corporation has achieved a landmark in Australian bioenergy by fully funding its SA1 Salisbury project and securing a renewable gas grid connection, advancing its transition to sustainable energy infrastructure.

Radiopharm Theranostics has bolstered its cash position with an $8 million placement from Lantheus Holdings, now its largest shareholder. New clinical data highlight promising advances in brain metastases detection and HER2-targeted radiopharmaceutical therapies.

Race Oncology has opened a second Australian clinical site for its Phase 1 trial of RC220 combined with doxorubicin in advanced solid tumours, aiming to speed patient enrolment and gather critical safety and efficacy data.

Opthea has completed the final patient visit in its pivotal COAST Phase 3 trial evaluating sozinibercept combined with aflibercept for wet AMD, with topline results expected early Q2 2025.

Legacy Minerals has identified a compelling new porphyry copper-gold drill target at its Glenlogan Project, following advanced geophysical surveys by partner S2 Resources. This discovery builds on last year’s drilling that revealed significant mineralization, positioning Glenlogan as a potential new player in the Macquarie Arc.